PARKHOSPSPark Medi World Limited
Healthcare · Medical Care Facilities · NSE · as of 2026-10-26 (delayed ~30 min in market hours)
Park Medi World Limited operates a network of hospitals. The company provides cardiac sciences, neurosciences - brain and spine, plastic and cosmetic surgery, general and laparoscopic surgery, renal sciences and kidney transplant, bone, orthopaedics, joint replacement and sports medicine, gastroenterology and surgical gastroenterology, cancer care, bone marrow transplant, iMARS / robot-assisted surgery. It also offers bariatric surgery, anaesthesiology, critical care, chest and respiratory diseases, dental care, dermatology, endocrinology, paediatrics, internal medicine and geriatrics, rheumatology, ENT, ophthalmology, obstetrics and gynaecology, interventional radiology and imaging, psychiatry, pathology and microbiology, paediatric surgery, fertility management, nuclear medicine services. It operates NABH accredited multi-super specialty hospitals under the Park brand name. Park Medi World Limited was founded in 2005 and is headquartered in Gurugram, India.
Price & Volume
Loading chart…
Key Ratios
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
None of the 16 pattern scanners currently detects a setup on PARKHOSPS — signals appear here automatically when one forms (checked on every data refresh). The Trade Plan on the right always provides stop-loss and target levels regardless.
The picture
- • Revenue growth: 19.3% YoY
- • Profit growth: 20.6% YoY
- • Debt/Equity: 0.17
- • Golden cross setup: SMA50 above SMA200
- • Trend strength (ADX): 52
- • Volume trend: 1.8x baseline
Bull case
- • Revenue growth: 19.3% YoY
- • Profit growth: 20.6% YoY
- • Debt/Equity: 0.17
- • Golden cross setup: SMA50 above SMA200
Bear case
- • Dividend yield: 0.00%
- • RSI: 27
- • MACD: bearish
- • 1-month return: -23.3%
Key risks
- • Momentum is fading versus the broader market
- • Dividend yield: 0.00%
- • RSI: 27
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹10.69). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.